| Name | Title | Contact Details |
|---|
Humanized Solutions is a Concord, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InCube Ventures is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
GDM's VACS software provides capture capabilities and collaborative tools using typically un-captured but critical visual information between patients, clinicians and medical specialists. VACS helps solve the problems today’s clinicians face relating to increased patient flow, less time available and increased demand for better outcomes. The VACS platform, which includes proprietary management software, digital capture/streaming and mobile applications, provides a new level of “rich media” capture, access, interaction and use of images, video, audio and other data elements. Management is currently focused on expanding the VACS platform internationally, to increase clinical efficiency and bridge the visual information gap in today’s growing clinical collaboration processes
CARWILD CORPORATION is a Old Mystic, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.